Drug:
Respiratory Syncytial Virus Vaccine, Adjuvanted
Brand:
Arexvy
Manufacturer /
TM Owner GSK
TM Owner GSK
Origin:
UK
Arexvy RSVPreF3 Vaccine for RSV Protection | Apple Globalcare
Arexvy is a recombinant vaccine designed to protect older adults against respiratory syncytial virus. It stimulates strong immune responses to reduce severe respiratory illness risk. Vaccination supports seasonal protection and helps prevent complications in vulnerable populations.
Strength:
0.5ml
Pack Size:
1s
Storage:
2°C to 8°C
Form:
Injection
Global Shipping : Reliable Global Distribution Network
Express Delivery : Priority Shipping for Every Order
Secure Payments : Trusted Payment Protection System
Disclaimer
All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the 'Manufacturer/ TM Owner' section in compliance with statutory requirements.
Read More
Secure Handling
24/7 Worldwide Support
Global Access
Worldwide Access to Health
Cold-Chain Expert
Excellence in Cold-Chain
Trusted Supply
Certified Medical Supply
Description
Disclaimer
Shipping
How to Order
Trusted & Reliable – Your Partner in Global Distribution.
We provide comprehensive lines of pharmaceutical products to support all your healthcare distribution needs.
